Advanced search
Publication Cover
Modern Rheumatology Volume 19, 2009 - Issue 4
Journal homepage
18
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Lack of association between tyrosine kinase 2 (TYK2) gene polymorphisms and susceptibility to SLE in a Japanese population

Chieko KyogokuDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, JapanCorrespondence[email protected]
,
Akio MorinobuDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan
,
Kunihiro NishimuraDepartment of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
,
Daisuke SugiyamaDepartment of Evidence-based Laboratory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
,
Hiroshi HashimotoDepartment of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan
,
Yoshiaki TokanoDepartment of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan
,
Tsuneyo MimoriDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
,
Chikashi TeraoDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan
,
Fumihiko MatsudaCenter for Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan
,
Takayoshi KunoDivision of Molecular Pharmacology and Pharmacogenomics, Department of Biochemistry and Molecular Biology, Kobe University Graduate School of Medicine, Kobe, Japan
&
Shunichi KumagaiDepartment of Clinical Pathology and Immunology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, Hyogo 650-0017, Japan
 show all
Pages 401-406 | Received 24 Feb 2009, Accepted 31 Mar 2009, Published online: 02 Jan 2014

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Wen-Hai Shao & Philip L Cohen. (2014) The role of tyrosine kinases in systemic lupus erythematosus and their potential as therapeutic targets. Expert Review of Clinical Immunology 10:5, pages 573-582.
Read now
Yan Liang, Yan Zhu, Yi Xia, Hui Peng, Xiao-Ke Yang, Yan-Yan Liu, Wang-Dong Xu, Hai-Feng Pan & Dong-Qing Ye. (2014) Therapeutic potential of tyrosine kinase 2 in autoimmunity. Expert Opinion on Therapeutic Targets 18:5, pages 571-580.
Read now

Articles from other publishers (15)

Mario Sestan, Nastasia Kifer, Todor Arsov, Matthew Cook, Julia Ellyard, Carola G. Vinuesa & Marija Jelusic. (2023) The Role of Genetic Risk Factors in Pathogenesis of Childhood-Onset Systemic Lupus Erythematosus. Current Issues in Molecular Biology 45:7, pages 5981-6002.
Crossref
Dionysis Nikolopoulos & Ioannis Parodis. (2023) Janus kinase inhibitors in systemic lupus erythematosus: implications for tyrosine kinase 2 inhibition. Frontiers in Medicine 10.
Crossref
Yong-Fei Wang, Yan Zhang, Zhiming Lin, Huoru Zhang, Ting-You Wang, Yujie Cao, David L. Morris, Yujun Sheng, Xianyong Yin, Shi-Long Zhong, Xiaoqiong Gu, Yao Lei, Jing He, Qi Wu, Jiangshan Jane Shen, Jing Yang, Tai-Hing Lam, Jia-Huang Lin, Zhi-Ming Mai, Mengbiao Guo, Yuanjia Tang, Yanhui Chen, Qin Song, Bo Ban, Chi Chiu Mok, Yong Cui, Liangjing Lu, Nan Shen, Pak C. Sham, Chak Sing Lau, David K. Smith, Timothy J. Vyse, Xuejun Zhang, Yu Lung Lau & Wanling Yang. (2021) Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups. Nature Communications 12:1.
Crossref
Felipe Mateus Pellenz, Cristine Dieter, Natália Emerim Lemos, Andrea Carla Bauer, Bianca Marmontel de Souza & Daisy Crispim. (2021) Association of TYK2 polymorphisms with autoimmune diseases: A comprehensive and updated systematic review with meta-analysis. Genetics and Molecular Biology 44:2.
Crossref
Zhi Li, Maxime Rotival, Etienne Patin, Frédérique Michel & Sandra Pellegrini. (2020) Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage. PLOS ONE 15:1, pages e0225289.
Crossref
Yong‐Fei Wang, Yu lung Lau & Wanling Yang. (2019) Genetic studies on systemic lupus erythematosus in East Asia point to population differences in disease susceptibility. American Journal of Medical Genetics Part C: Seminars in Medical Genetics.
Crossref
Qiong Yin, Liang-Cai Wu, Lu Zheng, Ming-Yu Han, Li-Ya Hu, Pian-Pian Zhao, Wei-Yang Bai, Xiao-Wei Zhu, Jiang-Wei Xia, Xiao-Bo Wang, Xing-Wei Zhang & Hou-Feng Zheng. (2018) Comprehensive assessment of the association between genes on JAK-STAT pathway (IFIH1, TYK2, IL-10) and systemic lupus erythematosus: a meta-analysis. Archives of Dermatological Research 310:9, pages 711-728.
Crossref
Liubing LiSi ChenQian WangChanyuan WuXiaoting WenFuning YangChenxi LiuFengchun ZhangYongzhe Li. (2017) GLIS3 and TYK2 Single Nucleotide Polymorphisms Are Not Associated with Dermatomyositis/Polymyositis in Chinese Han Population . Genetic Testing and Molecular Biomarkers 21:9, pages 565-570.
Crossref
Y H Lee & S-C Bae. (2016) Association between TYK2 polymorphisms and susceptibility to autoimmune rheumatic diseases: a meta-analysis . Lupus 25:12, pages 1307-1314.
Crossref
Sarfaraz Niazi. 2015. Biosimilars and Interchangeable Biologics. Biosimilars and Interchangeable Biologics 23 66 .
Liang Tang, Pengcheng Wan, Yong Wang, Jiabao Pan, Yan Wang & Bifeng Chen. (2015) Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population. Inflammation Research 64:10, pages 817-824.
Crossref
Zhi Li, Milica Gakovic, Josiane Ragimbeau, Maija-Leena Eloranta, Lars Rönnblom, Frédérique Michel & Sandra Pellegrini. (2013) Two Rare Disease-Associated Tyk2 Variants Are Catalytically Impaired but Signaling Competent. The Journal of Immunology 190:5, pages 2335-2344.
Crossref
Richard A. Stein. (2012) Direct-to-Consumer Genetic Testing. Journal of Information Technology Research 5:1, pages 35-67.
Crossref
Michael G. Tovey & Christophe Lallemand. (2011) Immunogenicity and other problems associated with the use of biopharmaceuticals. Therapeutic Advances in Drug Safety 2:3, pages 113-128.
Crossref
Michael G. Tovey & Christophe Lallemand. (2010) Safety, Tolerability, and Immunogenicity of Interferons. Pharmaceuticals 3:4, pages 1162-1186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.